Skip to main content
OpenTrials
Completed

NCT Number: NCT01157338

Clinical Significance of Retinal Emboli During Diagnostic and Therapeutic Cardiac Catheterization

Retinal emboli is a common phenomenon in cardiac catheterization. In this study the investigators evaluate the incidence of retinal emboli post diagnostic and therapeutic cardiac catheterization over 300 patients. The incidence was 6.3% and had no clinical sequel on visual acuity and visual field.

Completed

Looking for future studies?

Notify Me

Key information

Age range

52 year–68 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

shiraz University of medical sciences

Shiraz, Fars, 55318, Iran

About this study

Background and Purpose Cardiac catheterization may cause retinal embolization, a risk factor for cerebrovascular emboli and stroke. We describe the incidence of clinically silent and apparent retinal emboli following diagnostic and interventional coronary catheterization and associated risk factors.

Methods Three hundred selected patients attending a tertiary referral center for diagnostic and therapeutic cardiac catheterization were studied. Direct retinal examination and examination of the visual field and acuity were done before and after catheterization by a retinal specialist.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • every patient with diagnostic and therapeutic cardiac catheterization

Exclusion criteria

  • patient refusal to follow up ophthalmology
  • abscence of coronary disease in angiogram
  • abnormal retinal angiogram prior to study

Treatment and study plan

diagnostic cardiac catheterization

Procedure

coronary intervention: angiography

therapeutic cardiac catheterization

Procedure

cardiac catheterization: angioplasty

Primary outcomes

  1. retinal emboli

    retinal emboli detected by retinal especialist by direct examination

Secondary outcomes

  1. visual field

    visual field detected by ophthalmologist

  2. visual acuity

    snellen chart by ophthalmologist

Sponsors and collaborators

Lead sponsor

Shiraz University of Medical Sciences

Other

Registry information

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Jul 7, 2010
Registry last updated
Jul 7, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.